{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:57:23Z","timestamp":1785859043734,"version":"3.56.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1097\/01.aids.0000192070.95819.7c","type":"journal-article","created":{"date-parts":[[2005,10,26]],"date-time":"2005-10-26T04:01:56Z","timestamp":1130299316000},"page":"S47-S52","source":"Crossref","is-referenced-by-count":31,"title":["Health disparities among African-American and Hispanic drug injectors \u2013 HIV, AIDS, hepatitis B virus and hepatitis C virus: a review"],"prefix":"10.1097","volume":"19","author":[{"given":"Antonio L","family":"Estrada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl.","key":"R3-9-20210130","first-page":"S118","article-title":"Disparities in health status and substance use: ethnicity and socioeconomic factors","volume":"117","author":"Buka","year":"2002","journal-title":"Public Health Rep"},{"key":"R5-9-20210130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2105\/AJPH.89.1.14","article-title":"Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994","volume":"89","author":"McQuillan","year":"1999","journal-title":"Am J Public Health"},{"issue":"Suppl. 1","key":"R7-9-20210130","first-page":"S126","article-title":"Epidemiology of HIV\/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users","volume":"117","author":"Estrada","year":"2002","journal-title":"Public Health Rep"},{"key":"R8-9-20210130","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1086\/321819","article-title":"Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection","volume":"33","author":"Monga","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R9-9-20210130","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.284.4.450","article-title":"The natural history of hepatitis C virus infection: host, viral, and environmental factors","volume":"284","author":"Thomas","year":"2000","journal-title":"JAMA"},{"key":"R10-9-20210130","first-page":"30","article-title":"Seroepidemiology of viral infections among intravenous drug users in northern California","volume":"156","author":"Zeldis","year":"1992","journal-title":"West J Med"},{"key":"R11-9-20210130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/oxfordjournals.aje.a117639","article-title":"Seroepidemiology of hepatitis B virus in a population of injecting drug users","volume":"142","author":"Levine","year":"1995","journal-title":"Am J Epidemiol"},{"issue":"Suppl. 1","key":"R12-9-20210130","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1097\/00042560-199802001-00003","article-title":"The importance of preventing hepatitis C virus infection among injection drug users in the United States","volume":"18","author":"Alter","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R13-9-20210130","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/oxfordjournals.epirev.a036161","article-title":"Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions","volume":"16","author":"Levine","year":"1994","journal-title":"Epidemiol Rev"},{"key":"R14-9-20210130","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/339192","article-title":"Incidence and risk factors for acute hepatitis B in the United States, 1982\u20131998: implications for vaccination programs","volume":"185","author":"Goldstein","year":"2002","journal-title":"J Infect Dis"},{"key":"R15-9-20210130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF02386744","article-title":"Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area","volume":"77","author":"Thiede","year":"2000","journal-title":"J Urban Health"},{"key":"R18-9-20210130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2105\/AJPH.91.1.23","article-title":"Factors associated with prevalent hepatitis C: Differences among young adult injection drug users in lower and upper Manhattan, New York City","volume":"91","author":"Diaz","year":"2001","journal-title":"Am J Pub Health"},{"key":"R19-9-20210130","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00005792-199507000-00005","article-title":"Correlates of hepatitis C virus among injection drug users","volume":"74","author":"Thomas","year":"1995","journal-title":"Medicine"},{"key":"R20-9-20210130","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2105\/AJPH.86.5.655","article-title":"Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses","volume":"86","author":"Garfein","year":"1996","journal-title":"Am J Public Health"},{"key":"R21-9-20210130","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1128\/JCM.35.12.3274-3277.1997","article-title":"Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland","volume":"35","author":"Villano","year":"1997","journal-title":"J Clin Microbiol"},{"key":"R22-9-20210130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2105\/AJPH.91.1.42","article-title":"Sharing of drug preparation equipment as a risk factor for hepatitis C","volume":"91","author":"Hagan","year":"2001","journal-title":"Am J Pub Health"},{"key":"R25-9-20210130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/02791072.1998.10399699","article-title":"Drug use and HIV risks among African American, Mexican American, and Puerto Rican drug injectors","volume":"30","author":"Estrada","year":"1998","journal-title":"J Psychoactive Drugs"},{"key":"R26-9-20210130","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00002030-199204000-00013","article-title":"Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone maintenance programme. [Letter]","volume":"6","author":"Chamot","year":"1992","journal-title":"AIDS"},{"key":"R27-9-20210130","first-page":"589","article-title":"Prevalence of HIV and hepatitis B and self-reported injection risk behavior during detention among street-recruited injection drug users in Los Angeles County, 1994\u20131996","volume":"96","author":"Lopez-Zetina","year":"2001","journal-title":"Addiction"},{"key":"R28-9-20210130","first-page":"253","article-title":"The health of Hispanics in the southwestern United States: an epidemiological paradox","volume":"101","author":"Markides","year":"1986","journal-title":"Public Health Rep"},{"key":"R30-9-20210130","first-page":"1097","article-title":"Self-reports of HIV risk behavior by injecting drug users: are they reliable?","volume":"90","author":"Goldstein","year":"1995","journal-title":"Addiction"},{"key":"R31-9-20210130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1037\/0893-164X.13.1.33","article-title":"Hepatitis B validity of drug users' self-report","volume":"13","author":"Fisher","year":"1999","journal-title":"Psychol Addict Behav"},{"key":"R33-9-20210130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.aje.a009792","article-title":"Syringe exchange and risk of infection with hepatitis B and C viruses","volume":"149","author":"Hagan","year":"1999","journal-title":"Am J Epidemiol"},{"key":"R34-9-20210130","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.2105\/AJPH.85.11.1531","article-title":"Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program","volume":"85","author":"Hagan","year":"1995","journal-title":"Am J Pub Health"},{"key":"R35-9-20210130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/00365540050165875","article-title":"Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe\/needle exchange program","volume":"32","author":"Mansson","year":"2000","journal-title":"Scand J Infect Dis"},{"key":"R36-9-20210130","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/BF02351502","article-title":"Needle-exchange attendance and health care utilization promote entry into detoxification","volume":"76","author":"Strathdee","year":"1999","journal-title":"J Urban Hlth"},{"key":"R37-9-20210130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0740-5472(00)00104-5","article-title":"Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors","volume":"19","author":"Hagan","year":"2000","journal-title":"J Subst Abuse Treatment"},{"key":"R38-9-20210130","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00007435-200103000-00008","article-title":"Screening for chronic hepatitis B and C infections in an urban sexually transmitted disease clinic: rationale for integrating services","volume":"28","author":"Gunn","year":"2001","journal-title":"Sex Transm Dis"},{"issue":"RR01","key":"R39-9-20210130","first-page":"1","article-title":"Prevention and control of infections with hepatitis viruses in correctional settings.","volume":"52","year":"2003","journal-title":"MMWR"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003643-200511000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:04:45Z","timestamp":1785855885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200510003-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":29,"journal-issue":{"issue":"Suppl 3","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aids.0000192070.95819.7c","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}